Please use this identifier to cite or link to this item: http://dx.doi.org/10.25673/118718
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSoukup, Jens-
dc.contributor.authorPliquett, Rainer U.-
dc.date.accessioned2025-04-03T11:57:27Z-
dc.date.available2025-04-03T11:57:27Z-
dc.date.issued2025-
dc.identifier.urihttps://opendata.uni-halle.de//handle/1981185920/120676-
dc.identifier.urihttp://dx.doi.org/10.25673/118718-
dc.description.abstractBackground: The recently updated definition of sepsis considers pathophysiologic mechanisms to guide initial therapy. Clearly, generalized recommendations for sepsis therapy may be limited by pre-existing multimorbidity in addition to sepsis-related multi-organ failure. In particular, a recommendation regarding fluid rescue therapy may require adequate cardiac function and/or the absence of sepsis-induced cardiomyopathy. In all sepsis patients with compromised cardiac function or sepsis-induced cardiomyopathy, a patient-specific therapy regimen is required to prevent pulmonary edema and early death. Similarly, in sepsis, acute kidney injury with or without pre-existing chronic kidney disease requires attention to be paid to excretory renal function to avoid hypervolemia-mediated acute heart failure. In addition, hyponatremia related to intravascular hypovolemia may be explained by vasopressin stimulation. However, hypothetically, vasopressin hyporesponsiveness may contribute to sepsis-related acute kidney injury. In this review, relevant cardiorenal pathomechanisms will be assessed in the context of sepsis therapy. Conclusions: In conclusion, therapy for sepsis with acute kidney injury has to take cardiac comorbidity, if present, into account. The extent to which vasopressin hyporesponsiveness aggravates sepsis-mediated hypovolemia and renal insufficiency should remain a subject of further study.eng
dc.language.isoeng-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subject.ddc610-
dc.titleAcute kidney injury during sepsis and prognostic role of coexistent chronic heart failureeng
dc.typeArticle-
local.versionTypepublishedVersion-
local.bibliographicCitation.journaltitleJournal of Clinical Medicine-
local.bibliographicCitation.volume14-
local.bibliographicCitation.issue3-
local.bibliographicCitation.publishernameMDPI-
local.bibliographicCitation.publisherplaceBasel-
local.bibliographicCitation.doi10.3390/jcm14030964-
local.openaccesstrue-
dc.identifier.ppn1918956243-
cbs.publication.displayform2025-
local.bibliographicCitation.year2025-
cbs.sru.importDate2025-04-03T11:57:03Z-
local.bibliographicCitationEnthalten in Journal of Clinical Medicine - Basel : MDPI, 2012-
local.accessrights.dnbfree-
Appears in Collections:Open Access Publikationen der MLU

Files in This Item:
File Description SizeFormat 
jcm-14-00964-v2.pdf814.56 kBAdobe PDFThumbnail
View/Open